153 related articles for article (PubMed ID: 12614344)
1. Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-beta protein into synaptic terminals.
Gylys KH; Fein JA; Tan AM; Cole GM
J Neurochem; 2003 Mar; 84(6):1442-51. PubMed ID: 12614344
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E/Amyloid-β Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4.
Bilousova T; Melnik M; Miyoshi E; Gonzalez BL; Poon WW; Vinters HV; Miller CA; Corrada MM; Kawas C; Hatami A; Albay R; Glabe C; Gylys KH
Am J Pathol; 2019 Aug; 189(8):1621-1636. PubMed ID: 31108099
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex.
Arold S; Sullivan P; Bilousova T; Teng E; Miller CA; Poon WW; Vinters HV; Cornwell LB; Saing T; Cole GM; Gylys KH
Acta Neuropathol; 2012 Jan; 123(1):39-52. PubMed ID: 22020632
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges.
Bentley NM; Ladu MJ; Rajan C; Getz GS; Reardon CA
Biochem J; 2002 Aug; 366(Pt 1):273-9. PubMed ID: 12015813
[TBL] [Abstract][Full Text] [Related]
5. Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer's disease.
Lauderback CM; Hackett JM; Keller JN; Varadarajan S; Szweda L; Kindy M; Markesbery WR; Butterfield DA
Biochemistry; 2001 Feb; 40(8):2548-54. PubMed ID: 11327877
[TBL] [Abstract][Full Text] [Related]
6. A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.
Sadowski M; Pankiewicz J; Scholtzova H; Ripellino JA; Li Y; Schmidt SD; Mathews PM; Fryer JD; Holtzman DM; Sigurdsson EM; Wisniewski T
Am J Pathol; 2004 Sep; 165(3):937-48. PubMed ID: 15331417
[TBL] [Abstract][Full Text] [Related]
7. ApoE protects cortical neurones against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloid-beta peptide.
Drouet B; Fifre A; Pinçon-Raymond M; Vandekerckhove J; Rosseneu M; Guéant JL; Chambaz J; Pillot T
J Neurochem; 2001 Jan; 76(1):117-27. PubMed ID: 11145984
[TBL] [Abstract][Full Text] [Related]
8. Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.
Montoliu-Gaya L; Mulder SD; Veerhuis R; Villegas S
PLoS One; 2017; 12(11):e0188191. PubMed ID: 29155887
[TBL] [Abstract][Full Text] [Related]
9. Isoform-specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-beta peptide.
Stratman NC; Castle CK; Taylor BM; Epps DE; Melchior GW; Carter DB
Chem Phys Lipids; 2005 Oct; 137(1-2):52-61. PubMed ID: 16140289
[TBL] [Abstract][Full Text] [Related]
10. System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40.
Qin S; Colin C; Hinners I; Gervais A; Cheret C; Mallat M
J Neurosci; 2006 Mar; 26(12):3345-56. PubMed ID: 16554485
[TBL] [Abstract][Full Text] [Related]
11. Cerebral clearance of human amyloid-beta peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes.
Ito S; Ohtsuki S; Kamiie J; Nezu Y; Terasaki T
J Neurochem; 2007 Dec; 103(6):2482-90. PubMed ID: 17908238
[TBL] [Abstract][Full Text] [Related]
12. The binding of apolipoprotein E to oligomers and fibrils of amyloid-β alters the kinetics of amyloid aggregation.
Garai K; Verghese PB; Baban B; Holtzman DM; Frieden C
Biochemistry; 2014 Oct; 53(40):6323-31. PubMed ID: 25207746
[TBL] [Abstract][Full Text] [Related]
13. Aβ-oligomer uptake and the resulting inflammatory response in adult human astrocytes are precluded by an anti-Aβ single chain variable fragment in combination with an apoE mimetic peptide.
Montoliu-Gaya L; Mulder SD; Herrebout MAC; Baayen JC; Villegas S; Veerhuis R
Mol Cell Neurosci; 2018 Jun; 89():49-59. PubMed ID: 29625180
[TBL] [Abstract][Full Text] [Related]
14. Effect of apolipoprotein AII on the interaction of apolipoprotein E with beta-amyloid: some apo(E-AII) complexes inhibit the internalization of beta-amyloid in cultures of neuroblastoma cells.
Yamauchi K; Tozuka M; Hidaka H; Nakabayashi T; Sugano M; Kondo Y; Nakagawara A; Katsuyama T
J Neurosci Res; 2000 Nov; 62(4):608-14. PubMed ID: 11070505
[TBL] [Abstract][Full Text] [Related]
15. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner.
Lauderback CM; Kanski J; Hackett JM; Maeda N; Kindy MS; Butterfield DA
Brain Res; 2002 Jan; 924(1):90-7. PubMed ID: 11743999
[TBL] [Abstract][Full Text] [Related]
18. SDS-stable complex formation between native apolipoprotein E3 and beta-amyloid peptides.
Munson GW; Roher AE; Kuo YM; Gilligan SM; Reardon CA; Getz GS; LaDu MJ
Biochemistry; 2000 Dec; 39(51):16119-24. PubMed ID: 11123940
[TBL] [Abstract][Full Text] [Related]
19. High-affinity multivalent interactions between apolipoprotein E and the oligomers of amyloid-β.
Ghosh S; Sil TB; Dolai S; Garai K
FEBS J; 2019 Dec; 286(23):4737-4753. PubMed ID: 31287614
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence resonance energy transfer analysis of apolipoprotein E C-terminal domain and amyloid beta peptide (1-42) interaction.
Phu MJ; Hawbecker SK; Narayanaswami V
J Neurosci Res; 2005 Jun; 80(6):877-86. PubMed ID: 15880461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
